Translational PET Imaging of Nectin-4 Expression in Multiple Different Cancers with 68 Ga-N188
Journal of Nuclear Medicine · 2024
DOI: 10.2967/jnumed.123.266830 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Nuclear Medicine, 2024. Verfasst von Jianhua Zhang und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, Peking University First Hospital, Beijing, China. Hauptthemen laut MEDLINE: Cell Adhesion Molecules, Positron Emission Tomography Computed Tomography. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 24 Literaturangaben.
Abstract (Originalsprache)
Nectin cell adhesion molecule 4 (nectin-4) is a transmembrane protein overexpressed on a variety of cancers and plays an important role in oncogenic and metastatic processes. The nectin-4-targeted antibody-drug conjugate enfortumab vedotin has been approved for treating locally advanced or metastatic urothelial cancer, but the efficacy in other types of cancer remains to be explored. The aim of this study was to evaluate the feasibility of nectin-4-targeted PET imaging with 68Ga-N188 as a noninvasive method to quantify membranous nectin-4 expression in multiple tumor types-an approach that may provide insight for patient stratification and treatment selection.
Methods
Sixty-two patients with 16 types of cancer underwent head-to-head 68Ga-N188 and 18F-FDG PET/CT imaging for initial staging or detection of recurrence and metastases. Correlation between lesion SUVmax and nectin-4 expression determined by immunohistochemistry staining was analyzed in 36 of 62 patients.
Results
The SUVmax of 68Ga-N188 had a positive correlation with membranous nectin-4 expression in the various tumor types tested (r = 0.458; P = 0.005), whereas no association was observed between the SUVmax and cytoplasmic nectin-4 expression. The detection rates for patient-based analysis of 68Ga-N188 and 18F-FDG PET/CT examinations were comparable (95.00% [57/60] vs. 93.33% [56/60]). In patients with pancreatic cancer, 68Ga-N188 exhibited a potential advantage for detecting residual or locally recurrent tumors; this advantage may assist in clinical decision-making.
Conclusion
The correlation between nectin-4-targeted 68Ga-N188 PET imaging and membranous nectin-4 expression indicates the potential of 68Ga-N188 as an effective tool for selecting patients who may benefit from enfortumab vedotin treatment. The PET imaging results provided evidence to explore nectin-4-targeted therapy in a variety of tumors. 68Ga-N188 may improve the restaging of pancreatic cancer but requires further evaluation in a powered, prospective setting.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nuclear Medicine, Peking University First Hospital, Beijing, China.
- Department of Hepatobiliary and Pancreatic Surgery, Peking University First Hospital, Beijing, China.
- Department of Urology, Peking University First Hospital, Beijing, China.
- National Research Center for Genitourinary Oncology, Institute of Urology, Peking University, Beijing, China.
- Department of Nuclear Medicine, Peking University First Hospital, Beijing, China; yangxing2017@bjmu.edu.cn.
- Department of Central Laboratory, Peking University First Hospital, Beijing, China.
Zitieren
APA
Zhang, J., Duan, X., Chen, X., Zhang, Z., Sun, H., Shou, J., Zhao, G., Wang, J., Ma, Y., Yang, Y., Tian, X., Shen, Q., Yu, W., He, Z., Fan, Y., & Yang, X. (2024). Translational PET Imaging of Nectin-4 Expression in Multiple Different Cancers with 68 Ga-N188. Journal of Nuclear Medicine. https://doi.org/10.2967/jnumed.123.266830
Vancouver
Zhang J, Duan X, Chen X, Zhang Z, Sun H, Shou J, et al. Translational PET Imaging of Nectin-4 Expression in Multiple Different Cancers with 68 Ga-N188. Journal of Nuclear Medicine. 2024. doi:10.2967/jnumed.123.266830
BibTeX
@article{Zhang2024,
author = {Zhang, Jianhua and Duan, Xiaojiang and Chen, Xueqi and Zhang, Zhuochen and Sun, Hongwei and Shou, Jiayin and Zhao, Guangyu and Wang, Jianxin and Ma, Yongsu and Yang, Yinmo and Tian, Xiaodong and Shen, Qi and Yu, Wei and He, Zhisong and Fan, Yan and Yang, Xing},
title = {Translational PET Imaging of Nectin-4 Expression in Multiple Different Cancers with 68 Ga-N188},
journal = {Journal of Nuclear Medicine},
year = {2024},
doi = {10.2967/jnumed.123.266830}
}
EUVIMED